J 2023

Biomechanical Rupture Risk Assessment in Management of Patients with Abdominal Aortic Aneurysm in COVID-19 Pandemic

KUBÍČEK, Luboš, Radek VITASEK, David SCHWARZ, Robert STAFFA, Petr STRAKOS et. al.

Basic information

Original name

Biomechanical Rupture Risk Assessment in Management of Patients with Abdominal Aortic Aneurysm in COVID-19 Pandemic

Authors

KUBÍČEK, Luboš (203 Czech Republic, guarantor, belonging to the institution), Radek VITASEK (203 Czech Republic), David SCHWARZ (203 Czech Republic), Robert STAFFA (203 Czech Republic, belonging to the institution), Petr STRAKOS (203 Czech Republic) and Stanislav POLZER (203 Czech Republic)

Edition

Diagnostics, Basel, MDPI, 2023, 2075-4418

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30212 Surgery

Country of publisher

Sweden

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.600 in 2022

RIV identification code

RIV/00216224:14110/23:00130353

Organization unit

Faculty of Medicine

UT WoS

000909283300001

Keywords in English

abdominal aortic aneurysm; biomechanics; rupture risk; predictability; COVID-19

Tags

Tags

International impact, Reviewed
Změněno: 19/2/2024 15:23, Mgr. Tereza Miškechová

Abstract

V originále

Background: The acute phase of the COVID-19 pandemic requires a redefinition of healthcare system to increase the number of available intensive care units for COVID-19 patients. This leads to the postponement of elective surgeries including the treatment of abdominal aortic aneurysm (AAA). The probabilistic rupture risk index (PRRI) recently showed its advantage over the diameter criterion in AAA rupture risk assessment. Its major improvement is in increased specificity and yet has the same sensitivity as the maximal diameter criterion. The objective of this study was to test the clinical applicability of the PRRI method in a quasi-prospective patient cohort study. Methods: Nineteen patients (fourteen males, five females) with intact AAA who were postponed due to COVID-19 pandemic were included in this study. The PRRI was calculated at the baseline via finite element method models. If a case was diagnosed as high risk (PRRI > 3%), the patient was offered priority in AAA intervention. Cases were followed until 10 September 2021 and a number of false positive and false negative cases were recorded. Results: Each case was assessed within 3 days. Priority in intervention was offered to two patients with high PRRI. There were four false positive cases and no false negative cases classified by PRRI. In three cases, the follow-up was very short to reach any conclusion. Conclusions: Integrating PRRI into clinical workflow is possible. Longitudinal validation of PRRI did not fail and may significantly decrease the false positive rate in AAA treatment.